Aditxt, Inc. (NASDAQ:ADTX) Sees Large Decrease in Short Interest

Aditxt, Inc. (NASDAQ:ADTX) was the recipient of a large drop in short interest in the month of November. As of November 30th, there was short interest totalling 180,800 shares, a drop of 82.6% from the November 15th total of 1,040,000 shares. Currently, 1.3% of the company’s stock are sold short. Based on an average daily trading volume, of 2,800,000 shares, the short-interest ratio is currently 0.1 days.

Aditxt Price Performance

Aditxt stock traded up $0.01 during trading hours on Wednesday, reaching $0.36. The stock had a trading volume of 143,379 shares, compared to its average volume of 780,419. The company has a fifty day simple moving average of $0.71 and a 200-day simple moving average of $30.85. Aditxt has a 52 week low of $0.31 and a 52 week high of $380.00.

Insiders Place Their Bets

In other Aditxt news, major shareholder Financial Lp Hrt sold 25,534 shares of the business’s stock in a transaction that occurred on Wednesday, October 16th. The shares were sold at an average price of $1.17, for a total transaction of $29,874.78. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.72% of the company’s stock.

Aditxt Company Profile

Aditxt, Inc, a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues.